Can the early stages of cervical cancer be cured?

Cervical cancer progresses slowly and is a preventable and curable disease. The cure rate of early cervical cancer has been improved, largely due to early detection, early diagnosis and early treatment of cervical cancer. Since the carcinoma in situ of early cervical cancer is confined to the skin or mucous membranes, without metastasis or deep infiltration, the 5-year survival rate can reach more than 90% with effective treatment, and the cure rate of early cervical cancer found under a microscope has reached 100%.

According to relevant statistics, the cure rate of early cervical cancer is 90-92%, which is much higher than that of late stage. Some patients in late stage with pathological stage at the end of late stage are almost incurable. It should be noted that cervical cancer is the only solid tumor with a clear cause among all cancers. Its occurrence and development over 10 years have led to qualitative changes from quantitative changes. If it can be discovered and diagnosed in the precancerous stage, and then further treated and tested, the cure rate of early cervical cancer will be greatly improved. Experts also pointed out that the earlier the discovery and treatment, the higher the cure rate.

The key to early detection of cervical cancer is that female friends should pay attention to the health of their reproductive system, conduct regular gynecological examinations, screen high-risk groups for cervical cancer, and continuously monitor and intervene in high-risk factors, which is of great significance for early detection of cervical cancer and stopping further deterioration of cancer.

Generally, those who are suspected of cervical cancer or have similar symptoms need to go to the hospital for further diagnosis. Using iodine test, cytology test, HPV test, and biopsy to make the final diagnosis, clarify cervical cancer and the extent of cancer, and provide reference for the next treatment method.

The cure rate of early cervical cancer depends on the treatment method, which is mainly based on surgery, combined with radiotherapy and anticancer drugs. Appropriate standardized comprehensive treatment is the essence of effectively improving the cure rate of early cervical cancer. A successful surgical treatment means that a patient will be reborn.

In addition to medical treatment, the key factor to improve the cure rate of early cervical cancer comes from the patients themselves. Patients should take good care of their physiology and spirit. Experts pointed out that ginsenoside Rh2 can induce tumor cells to differentiate into normal cells, which is beneficial to controlling tumor development. It can induce tumor cell apoptosis to form apoptotic bodies after cell disintegration without causing inflammatory reactions in surrounding tissues. Early cervical cancer patients can strengthen local control, reduce possible micro-metastases, shrink tumors, and increase the success rate of surgery with ginsenoside Rh2 (such as "Jinxing" capsules produced by Hainan Asia Pharmaceutical). It is the best auxiliary drug for cancer patients.

On the other hand, mental conditioning of cervical cancer patients is also very important, which has a direct impact on the long-term efficacy of the disease. Medical staff and their families should help patients adjust their mental state, treat cervical cancer correctly, encourage patients to set future life goals, and overcome mental and emotional tension. Practice shows that cervical cancer patients who are mentally prepared, have the ability to bear, have a cheerful personality, and have the confidence to overcome cancer can promote the cure rate of early cervical cancer.

Early cervical cancer may not cause any discomfort and is often discovered during physical examinations and censuses. Compared with gynecological tumors such as endometrial cancer and ovarian cancer, early cervical cancer has more obvious symptoms, a slow course, and slow metastasis. Therefore, early detection and diagnosis, early treatment, and early killing of the tumor in the cradle can effectively improve the cure rate of early cervical cancer.